By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.





Company News
Medivir (MVRBF) Initiates Phase IIa Study Of MIV-711 In Knee Osteoarthritis 1/28/2016 10:30:58 AM
Medivir (MVRBF): OLYSIO Sales During The Fourth Quarter 2015 1/26/2016 10:16:02 AM
Janssen Pharmaceutical, Medivir (MVRBF) Terminate AL-704 Phase I for Treatment of Hepatitis C 12/21/2015 6:24:41 AM
Medivir (MVRBF) – Interim Report, Third Quarter 2015 11/20/2015 7:24:47 AM
Medivir (MVRBF) Terminates the ADAM8 Inhibitor Project for Pancreatic Cancer 11/17/2015 6:13:06 AM
Medivir (MVRBF) Announces That Janssen Pharmaceutical Has Started A Phase IIa Study To Evaluate The Effect Of Simeprevir In Combination With Odalasvir And AL-335 10/16/2015 11:05:18 AM
Medivir (MVRBF): OLYSIO Sales During The Third Quarter 2015 10/13/2015 11:30:43 AM
Medivir (MVRBF) To Merge Research And Development And Implement Changes Within The Management Group 9/16/2015 12:02:23 PM
Medivir (MVRBF) – Interim Report, Second Quarter 2015 8/20/2015 8:55:11 AM
Medivir (MVRBF) Announces That Janssen Pharmaceutical Has Started A Phase I Study To Evaluate The Effect Of Simeprevir And Odalasvir On AL-335 Pharmacokinetics 8/3/2015 11:32:57 AM
12345678910...
//-->